213 related articles for article (PubMed ID: 24721789)
1. Analysis of determinants in filovirus glycoproteins required for tetherin antagonism.
Gnirß K; Fiedler M; Krämer-Kühl A; Bolduan S; Mittler E; Becker S; Schindler M; Pöhlmann S
Viruses; 2014 Apr; 6(4):1654-71. PubMed ID: 24721789
[TBL] [Abstract][Full Text] [Related]
2. A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism.
González-Hernández M; Hoffmann M; Brinkmann C; Nehls J; Winkler M; Schindler M; Pöhlmann S
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669839
[TBL] [Abstract][Full Text] [Related]
3. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
Brinkmann C; Nehlmeier I; Walendy-Gnirß K; Nehls J; González Hernández M; Hoffmann M; Qiu X; Takada A; Schindler M; Pöhlmann S
J Virol; 2016 Dec; 90(24):11075-11086. PubMed ID: 27707924
[TBL] [Abstract][Full Text] [Related]
4. The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherin.
Kühl A; Banning C; Marzi A; Votteler J; Steffen I; Bertram S; Glowacka I; Konrad A; Stürzl M; Guo JT; Schubert U; Feldmann H; Behrens G; Schindler M; Pöhlmann S
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S850-60. PubMed ID: 21987761
[TBL] [Abstract][Full Text] [Related]
5. Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin.
Radoshitzky SR; Dong L; Chi X; Clester JC; Retterer C; Spurgers K; Kuhn JH; Sandwick S; Ruthel G; Kota K; Boltz D; Warren T; Kranzusch PJ; Whelan SP; Bavari S
J Virol; 2010 Oct; 84(20):10569-80. PubMed ID: 20686043
[TBL] [Abstract][Full Text] [Related]
6. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.
Kaletsky RL; Francica JR; Agrawal-Gamse C; Bates P
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2886-91. PubMed ID: 19179289
[TBL] [Abstract][Full Text] [Related]
7. Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism.
Vande Burgt NH; Kaletsky RL; Bates P
Viruses; 2015 Oct; 7(10):5587-602. PubMed ID: 26516900
[TBL] [Abstract][Full Text] [Related]
8. Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.
Lopez LA; Yang SJ; Hauser H; Exline CM; Haworth KG; Oldenburg J; Cannon PM
J Virol; 2010 Jul; 84(14):7243-55. PubMed ID: 20444895
[TBL] [Abstract][Full Text] [Related]
9. The VP40 protein of Marburg virus exhibits impaired budding and increased sensitivity to human tetherin following mouse adaptation.
Feagins AR; Basler CF
J Virol; 2014 Dec; 88(24):14440-50. PubMed ID: 25297995
[TBL] [Abstract][Full Text] [Related]
10. Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.
Radoshitzky SR; Warfield KL; Chi X; Dong L; Kota K; Bradfute SB; Gearhart JD; Retterer C; Kranzusch PJ; Misasi JN; Hogenbirk MA; Wahl-Jensen V; Volchkov VE; Cunningham JM; Jahrling PB; Aman MJ; Bavari S; Farzan M; Kuhn JH
J Virol; 2011 Sep; 85(17):8502-13. PubMed ID: 21697477
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane interactions of HIV-1 Vpu and tetherin.
Guo F; Liang C
Curr HIV Res; 2012 Jun; 10(4):292-7. PubMed ID: 22524177
[TBL] [Abstract][Full Text] [Related]
12. Ebola Virus Glycoprotein Promotes Enhanced Viral Egress by Preventing Ebola VP40 From Associating With the Host Restriction Factor BST2/Tetherin.
Gustin JK; Bai Y; Moses AV; Douglas JL
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S181-90. PubMed ID: 25821226
[TBL] [Abstract][Full Text] [Related]
13. Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts.
Lopez LA; Yang SJ; Exline CM; Rengarajan S; Haworth KG; Cannon PM
J Virol; 2012 May; 86(10):5467-80. PubMed ID: 22398279
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Lassa and Marburg virus production by tetherin.
Sakuma T; Noda T; Urata S; Kawaoka Y; Yasuda J
J Virol; 2009 Mar; 83(5):2382-5. PubMed ID: 19091864
[TBL] [Abstract][Full Text] [Related]
15. Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression.
Gnirss K; Kühl A; Karsten C; Glowacka I; Bertram S; Kaup F; Hofmann H; Pöhlmann S
Virology; 2012 Mar; 424(1):3-10. PubMed ID: 22222211
[TBL] [Abstract][Full Text] [Related]
16. Calu-3 cells are largely resistant to entry driven by filovirus glycoproteins and the entry defect can be rescued by directed expression of DC-SIGN or cathepsin L.
González-Hernández M; Müller A; Hoenen T; Hoffmann M; Pöhlmann S
Virology; 2019 Jun; 532():22-29. PubMed ID: 30999160
[TBL] [Abstract][Full Text] [Related]
17. Filovirus entry: a novelty in the viral fusion world.
Hunt CL; Lennemann NJ; Maury W
Viruses; 2012 Feb; 4(2):258-75. PubMed ID: 22470835
[TBL] [Abstract][Full Text] [Related]
18. Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.
Vigan R; Neil SJ
J Virol; 2010 Dec; 84(24):12958-70. PubMed ID: 20926557
[TBL] [Abstract][Full Text] [Related]
19. Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance.
Kmiec D; Iyer SS; Stürzel CM; Sauter D; Hahn BH; Kirchhoff F
mBio; 2016 Aug; 7(4):. PubMed ID: 27531907
[TBL] [Abstract][Full Text] [Related]
20. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1.
Carette JE; Raaben M; Wong AC; Herbert AS; Obernosterer G; Mulherkar N; Kuehne AI; Kranzusch PJ; Griffin AM; Ruthel G; Dal Cin P; Dye JM; Whelan SP; Chandran K; Brummelkamp TR
Nature; 2011 Aug; 477(7364):340-3. PubMed ID: 21866103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
